| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1159/000093603 |
| P698 | PubMed publication ID | 16874019 |
| P50 | author | Robert M. Mader | Q38639772 |
| P2093 | author name string | Robert M Mader | |
| P2860 | cites work | PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. | Q40497377 |
| Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. | Q40582817 | ||
| The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression | Q42441491 | ||
| Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer | Q43566349 | ||
| High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection | Q44141769 | ||
| Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. | Q44763095 | ||
| The DCC protein and prognosis in colorectal cancer | Q44846916 | ||
| Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity | Q45285628 | ||
| Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study | Q46465639 | ||
| Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. | Q51597657 | ||
| Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. | Q53878417 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | Q27824786 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 | ||
| Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study | Q28348036 | ||
| Molecular predictors of survival after adjuvant chemotherapy for colon cancer | Q28363159 | ||
| Mutational analysis of the tyrosine phosphatome in colorectal cancers | Q34322220 | ||
| Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? | Q34546887 | ||
| The clinical importance and prognostic implications of microsatellite instability in sporadic cancer | Q35092208 | ||
| Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer | Q35596287 | ||
| Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? | Q35875960 | ||
| Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis | Q36076356 | ||
| The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer | Q36616245 | ||
| Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence | Q36641715 | ||
| Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases | Q36694790 | ||
| Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling | Q38336994 | ||
| Prognostic significance of calcium-binding protein S100A4 in colorectal cancer | Q38454622 | ||
| Converging patterns of colorectal cancer mortality in Europe | Q38475320 | ||
| P433 | issue | 7 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 334-341 | |
| P577 | publication date | 2006-07-03 | |
| P1433 | published in | Onkologie | Q15759087 |
| P1476 | title | Links between biology, prognosis and prediction of response to chemotherapy in colorectal cancer | |
| P478 | volume | 29 |
| Q46709012 | A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients |
| Q38429245 | Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls |
| Q38432054 | Measurement of DPD and TS transcripts aimed to predict clinical benefit from fluoropyrimidines: confirmation of the trend in Russian colorectal cancer series and caution regarding the gene referees |
Search more.